Market Research

Organoids Market Size, Share & Trends Analysis Report By Type (Neural Organoids, Hepatic Organoids, Intestinal Organoids, Other Organoids), By Method (General Submerged Method for Organoid Culture, Crypt Organoid Culture Techniques, Air Liquid Interface (

Best Price Guarantee Publisher Published Date SKU
from $3,500 Straits Research November, 2024 STRA19656105
Best Price Guarantee
Price from $3,500
Publisher Straits Research
Published Date November, 2024
SKU STRA19656105

Organoids Market Analysis and Insights

The Organoids Market size is anticipated to reach USD 544.81 million in 2024 and it is projected to reach USD 2.07billion by 2033, growing at a CAGR of 23.11% during the forecast period.

The Global Organoids Market Analysis report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include types, applications, and competitor analysis.

The Global Organoids Market growth, Size report provides a comprehensive analysis of the Biotechnology industry, analyzes and identifies changes in market conditions set to impact future business decisions by analyzing.

Research Methodology

Our research methodology constitutes a mix of secondary & primary research which ideally starts from exhaustive data mining, conducting primary interviews (suppliers/distributors/end-users), and formulating insights, estimates, growth rates accordingly. Final primary validation is a mandate to confirm our research findings with Key Opinion Leaders (KoLs), Industry Experts, Organoids Market includes major supplies & Independent Consultants among others.

Global Market Scope and Organoids Market

The scope of the report is to provide a 360-degree view of the market outlook by assessing the entire value chain and analyzing the key Organoids Market trends from 2024 to 2032 underlying in specific geographies. Qualitative and quantitative aspects are interlinked to provide rationales on market numbers, CAGR, and forecasts.

Organoids Market Country Level Analysis

The Global Organoids Market Industry Analysis Research Report provides a basic overview of industry dominating market share expected 2024 to 2032. A detailed section on Organoids Market share and status of critical industries is included in the report, covering. Market Segment by Regions (North America, Europe, Asia Pacific, South America and The Middle East and Africa), coverage with region wise data from 2024 to 2032.

Top Players in Organoids Market

Some of the other major highlights of the demand for Organoids Market include analysis, purchasing volume, prices, pricing analysis, and regulatory framework. Coverage on manufacturing structure, distribution channels, and Porter’s Five Forces analysis are also incorporated in the scope to provide analysis on the demand and supply side. This is anticipated to create opportunities for the growth of the Organoids Market during the forecast period.


    Market Segmentation

    The Global Organoids Market Share, Demand provides the most up-to-date Biotechnology industry data on the actual market situation, size, trends and future outlook. The research includes historic data from 2021 to 2023 and forecasts until 2032.

    • By Type



      • Neural Organoids


      • Hepatic Organoids


      • Intestinal Organoids


      • Other Organoids






    • By Method



      • General Submerged Method for Organoid Culture


      • Crypt Organoid Culture Techniques


      • Air Liquid Interface (ALI) Method for Organoid Culture


      • Clonal Organoids from Lgr5+ Cells


      • Brain and Retina Organoid Formation Protocol


      • Others






    • By Source



      • Primary Tissues


      • Stem Cells


        • Induced Pluripotent Stem Cells (iPSCs)
        • Others






    • By Applications



      • Developmental Biology


      • Personalized Medicine


      • Regenerative Medicine


      • Disease Pathology Studies


      • Drug Toxicity & Efficacy Testing






    • By End-User



      • Pharmaceutical and Biotechnology Companies


      • Academic and Research Institutions


      • Hospitals and Diagnostic Labs


      • Others






    Regions Coverd
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Spain
      • Italy
      • Russia
      • Nordic
      • Benelux
      • Rest of Europe
    • APAC
      • China
      • Korea
      • Japan
      • India
      • Australia
      • Singapore
      • Taiwan
      • South East Asia
      • Rest of Asia-Pacific
    • Middle East and Africa
      • UAE
      • Turkey
      • Saudi Arabia
      • South Africa
      • Egypt
      • Nigeria
      • Rest of MEA
    • LATAM
      • Brazil
      • Mexico
      • Argentina
      • Chile
      • Colombia
      • Rest of LATAM

    Reasons for Doing the Study:

    This report is an update of an earlier (2023) Research study. Since the previous edition of this report was published, the Public Safety and Security market has continued to evolve. In particular, the overall market growth rates forecast in the previous edition now appear to have been too high, extending the time-line for the market’s development. In order to give its readers, the most up-to-date and accurate assessment of future market opportunities.


    1 Executive Summary
    2 Research Scope & Segmentation
    2.1 Research Objectives
    2.2 Limitations & Assumptions
    2.3 Market Scope & Segmentation
    2.4 Currency & Pricing Considered
    3 Market Opportunity Assessment
    3.1 Emerging Regions / Countries
    3.2 Emerging Companies
    3.3 Emerging Applications / End Use
    4 Market Trends
    4.1 Drivers
    4.2 Market Warning Factors
    4.3 Latest Macro Economic Indicators
    4.4 Geopolitical Impact
    4.5 Technology Factors
    5 Market Assessment
    5.1 Porters Five Forces Analysis
    5.2 Value Chain Analysis
    6 Global Organoids Market Size Analysis
    6.1 By Type
    6.1.1 Neural Organoids
    6.1.2 Hepatic Organoids
    6.1.3 Intestinal Organoids
    6.1.4 Other Organoids
    6.2 By Method
    6.2.1 General Submerged Method for Organoid Culture
    6.2.2 Crypt Organoid Culture Techniques
    6.2.3 Air Liquid Interface (ALI) Method for Organoid Culture
    6.2.4 Clonal Organoids from Lgr5+ Cells
    6.2.5 Brain and Retina Organoid Formation Protocol
    6.2.6 Others
    6.3 By Source
    6.3.1 Primary Tissues
    6.3.2 Stem Cells
    6.3.2.1 Induced Pluripotent Stem Cells (iPSCs)
    6.3.2.2 Others
    6.4 By Applications
    6.4.1 Developmental Biology
    6.4.2 Personalized Medicine
    6.4.3 Regenerative Medicine
    6.4.4 Disease Pathology Studies
    6.4.5 Drug Toxicity & Efficacy Testing
    6.5 By End-User
    6.5.1 Pharmaceutical and Biotechnology Companies
    6.5.2 Academic and Research Institutions
    6.5.3 Hospitals and Diagnostic Labs
    6.5.4 Others
    7 North America Market Analysis
    7.1 By Type
    7.1.1 Neural Organoids
    7.1.2 Hepatic Organoids
    7.1.3 Intestinal Organoids
    7.1.4 Other Organoids
    7.2 By Method
    7.2.1 General Submerged Method for Organoid Culture
    7.2.2 Crypt Organoid Culture Techniques
    7.2.3 Air Liquid Interface (ALI) Method for Organoid Culture
    7.2.4 Clonal Organoids from Lgr5+ Cells
    7.2.5 Brain and Retina Organoid Formation Protocol
    7.2.6 Others
    7.3 By Source
    7.3.1 Primary Tissues
    7.3.2 Stem Cells
    7.3.2.1 Induced Pluripotent Stem Cells (iPSCs)
    7.3.2.2 Others
    7.4 By Applications
    7.4.1 Developmental Biology
    7.4.2 Personalized Medicine
    7.4.3 Regenerative Medicine
    7.4.4 Disease Pathology Studies
    7.4.5 Drug Toxicity & Efficacy Testing
    7.5 By End-User
    7.5.1 Pharmaceutical and Biotechnology Companies
    7.5.2 Academic and Research Institutions
    7.5.3 Hospitals and Diagnostic Labs
    7.5.4 Others
    7.5 U.S.
    7.6 Canada
    8 Europe Market Analysis
    8.1 By Type
    8.1.1 Neural Organoids
    8.1.2 Hepatic Organoids
    8.1.3 Intestinal Organoids
    8.1.4 Other Organoids
    8.2 By Method
    8.2.1 General Submerged Method for Organoid Culture
    8.2.2 Crypt Organoid Culture Techniques
    8.2.3 Air Liquid Interface (ALI) Method for Organoid Culture
    8.2.4 Clonal Organoids from Lgr5+ Cells
    8.2.5 Brain and Retina Organoid Formation Protocol
    8.2.6 Others
    8.3 By Source
    8.3.1 Primary Tissues
    8.3.2 Stem Cells
    8.3.2.1 Induced Pluripotent Stem Cells (iPSCs)
    8.3.2.2 Others
    8.4 By Applications
    8.4.1 Developmental Biology
    8.4.2 Personalized Medicine
    8.4.3 Regenerative Medicine
    8.4.4 Disease Pathology Studies
    8.4.5 Drug Toxicity & Efficacy Testing
    8.5 By End-User
    8.5.1 Pharmaceutical and Biotechnology Companies
    8.5.2 Academic and Research Institutions
    8.5.3 Hospitals and Diagnostic Labs
    8.5.4 Others
    8.5 U.K.
    8.6 Germany
    8.7 France
    8.8 Spain
    8.9 Italy
    8.10 Russia
    8.11 Nordic
    8.12 Benelux
    8.13 Rest of Europe
    9 APAC Market Analysis
    9.1 By Type
    9.1.1 Neural Organoids
    9.1.2 Hepatic Organoids
    9.1.3 Intestinal Organoids
    9.1.4 Other Organoids
    9.2 By Method
    9.2.1 General Submerged Method for Organoid Culture
    9.2.2 Crypt Organoid Culture Techniques
    9.2.3 Air Liquid Interface (ALI) Method for Organoid Culture
    9.2.4 Clonal Organoids from Lgr5+ Cells
    9.2.5 Brain and Retina Organoid Formation Protocol
    9.2.6 Others
    9.3 By Source
    9.3.1 Primary Tissues
    9.3.2 Stem Cells
    9.3.2.1 Induced Pluripotent Stem Cells (iPSCs)
    9.3.2.2 Others
    9.4 By Applications
    9.4.1 Developmental Biology
    9.4.2 Personalized Medicine
    9.4.3 Regenerative Medicine
    9.4.4 Disease Pathology Studies
    9.4.5 Drug Toxicity & Efficacy Testing
    9.5 By End-User
    9.5.1 Pharmaceutical and Biotechnology Companies
    9.5.2 Academic and Research Institutions
    9.5.3 Hospitals and Diagnostic Labs
    9.5.4 Others
    9.5 China
    9.6 Korea
    9.7 Japan
    9.8 India
    9.9 Australia
    9.10 Taiwan
    9.11 South East Asia
    9.12 Rest of Asia-Pacific
    10 Middle East and Africa Market Analysis
    10.1 By Type
    10.1.1 Neural Organoids
    10.1.2 Hepatic Organoids
    10.1.3 Intestinal Organoids
    10.1.4 Other Organoids
    10.2 By Method
    10.2.1 General Submerged Method for Organoid Culture
    10.2.2 Crypt Organoid Culture Techniques
    10.2.3 Air Liquid Interface (ALI) Method for Organoid Culture
    10.2.4 Clonal Organoids from Lgr5+ Cells
    10.2.5 Brain and Retina Organoid Formation Protocol
    10.2.6 Others
    10.3 By Source
    10.3.1 Primary Tissues
    10.3.2 Stem Cells
    10.3.2.1 Induced Pluripotent Stem Cells (iPSCs)
    10.3.2.2 Others
    10.4 By Applications
    10.4.1 Developmental Biology
    10.4.2 Personalized Medicine
    10.4.3 Regenerative Medicine
    10.4.4 Disease Pathology Studies
    10.4.5 Drug Toxicity & Efficacy Testing
    10.5 By End-User
    10.5.1 Pharmaceutical and Biotechnology Companies
    10.5.2 Academic and Research Institutions
    10.5.3 Hospitals and Diagnostic Labs
    10.5.4 Others
    10.5 UAE
    10.6 Turkey
    10.7 Saudi Arabia
    10.8 South Africa
    10.9 Egypt
    10.10 Nigeria
    10.11 Rest of MEA
    11 LATAM Market Analysis
    11.1 By Type
    11.1.1 Neural Organoids
    11.1.2 Hepatic Organoids
    11.1.3 Intestinal Organoids
    11.1.4 Other Organoids
    11.2 By Method
    11.2.1 General Submerged Method for Organoid Culture
    11.2.2 Crypt Organoid Culture Techniques
    11.2.3 Air Liquid Interface (ALI) Method for Organoid Culture
    11.2.4 Clonal Organoids from Lgr5+ Cells
    11.2.5 Brain and Retina Organoid Formation Protocol
    11.2.6 Others
    11.3 By Source
    11.3.1 Primary Tissues
    11.3.2 Stem Cells
    11.3.2.1 Induced Pluripotent Stem Cells (iPSCs)
    11.3.2.2 Others
    11.4 By Applications
    11.4.1 Developmental Biology
    11.4.2 Personalized Medicine
    11.4.3 Regenerative Medicine
    11.4.4 Disease Pathology Studies
    11.4.5 Drug Toxicity & Efficacy Testing
    11.5 By End-User
    11.5.1 Pharmaceutical and Biotechnology Companies
    11.5.2 Academic and Research Institutions
    11.5.3 Hospitals and Diagnostic Labs
    11.5.4 Others
    11.5 Brazil
    11.6 Mexico
    11.7 Argentina
    11.8 Chile
    11.9 Colombia
    11.10 Rest of LATAM
    12 Competitive Landscape
    12.1 Global Organoids Market Share By Players
    12.2 M & A Agreements & Collaboration Analysis
    13 Market Players Assessment
    13.2 DefiniGen
    13.3 PreComb
    13.4 Danaher Corporation (Cellesce & Molecular Devices)
    13.5 Newcells
    13.6 Crown Biosciences
    13.7 Ncardia
    13.8 Cell Microsystems
    13.9 Corning Incorporated
    13.10 AMS Biotechnology (Europe) Limited
    13.11 Greiner Bio-One
    13.12 Hubrecht Organoid Technology (HUB)
    13.13 Organovo, Inc.
    13.14 InSphero
    14 Research Methodology
    14.1 Research Data
    14.1.1 Secondary Data
    14.1.1.1 Major secondary sources
    14.1.1.2 Key data from secondary sources
    14.1.2 Primary Data
    14.1.2.1 Key data from primary sources
    14.1.2.2 Breakdown of primaries
    14.1.3 Secondary And Primary Research
    14.1.3.1 Key industry insights
    14.2 Market Size Estimation
    14.2.1 Bottom-Up Approach
    14.2.2 Top-Down Approach
    14.2.3 Market Projection
    14.3 Research Assumptions
    14.3.1 Assumptions
    14.4 Limitations
    14.5 Risk Assessment
    15 Appendix
    15.1 Discussion Guide
    15.2 Customization Options
    15.3 Related Reports
    16 Disclaimer

    $3,500
    $4,500

    Research Assistance

    US: 800.298.5699
    Int'l: +1.240.747.3093
    Live help
    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook

    Other tasks

    Cookie Settings